TransPharma Medical Ltd. Announces Successful Results of a Phase 1 Clinical Trial of ViaDerm-Calcitonin for the Treatment of Musculoskeletal Disorders

Published: Jan 11, 2011

(BUSINESS WIRE)--TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today successful results of a Phase I clinical trial of its self-applied ViaDerm-Calcitonin product for the treatment of musculoskeletal disorders such as osteoarthritis and musculoskeletal pain.

Back to news